Pricing Log in Create free account

ENDRA Life Sciences Inc. (NDRA) vs Inotiv, Inc. (NOTVQ)

ENDRA Life Sciences Inc. and Inotiv, Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.7M against $2.8M — 2.7× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −17.1%) and the lower return on invested capital (−539.9% vs −6.19%). Across the 16 metrics below, ENDRA Life Sciences Inc. leads on 9 and Inotiv, Inc. on 7.

Valuation

Metric NDRA NOTVQ Diagnostics & Research median
P/E n/m n/m 35.56
P/S 17.54 0.00 4.37
P/B 0.99 0.00 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 60.99 24.35
EV/Sales 2.22 1.57 5.51
Earnings yield (133.33%) (25,300.00%) (1.89%)
Free cash flow yield (124.95%) (2,858.05%) (0.15%)

Profitability

Metric NDRA NOTVQ Diagnostics & Research median
Gross margin 0.00% 22.94% 50.89%
Operating margin 0.00% (9.48%) (8.57%)
Net margin 0.00% (17.14%) (6.37%)
Free cash flow margin 0.00% (1.95%) 0.00%
Return on equity (152.04%) (74.09%) (2.92%)
Return on assets (110.08%) (11.85%) (6.71%)
Return on invested capital (539.89%) (6.19%) 0.00%

Growth

Metric NDRA NOTVQ Diagnostics & Research median
Revenue growth (TTM) — 5.61% 7.69%
EPS growth (last fiscal year) 84.32% 49.64% 25.92%
Revenue growth, 5-year CAGR — 53.36% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 7.10 0.27 2.02
Net debt to EBITDA 0.14 12.68 0.70

Dividend

Metric NDRA NOTVQ Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NDRA NOTVQ Diagnostics & Research median
Market cap 7.65m 2.79m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack